Home/Filings/4/0001209191-20-012155
4//SEC Filing

Morris Charles Q 4

Accession 0001209191-20-012155

CIK 0001428522other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 6:00 PM ET

Size

10.6 KB

Accession

0001209191-20-012155

Insider Transaction Report

Form 4
Period: 2020-02-20
Morris Charles Q
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-02-20+30,00030,000 total
    Exercise: $19.96Exp: 2030-02-20Common Stock (30,000 underlying)
  • Award

    Common Stock

    2020-02-20+20,00035,000 total
Footnotes (2)
  • [F1]The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in three substantially equal annual installments on each of the first three anniversaries of the grant date of February 20, 2020, subject to continued service with RDUS through such dates.
  • [F2]25% of the shares subject to the stock option shall vest on February 20, 2021, and the remaining shares shall vest in substantially equal monthly installments over the following three years, subject to continued service with RDUS through such dates.

Issuer

Radius Health, Inc.

CIK 0001428522

Entity typeother

Related Parties

1
  • filerCIK 0001489966

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 6:00 PM ET
Size
10.6 KB